Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Protein misassembly and aggregation as potential convergence points for non-genetic causes of chronic mental illness
Nicholas J. Bradshaw, Carsten Korth
Molecular Psychiatry (2018) Vol. 24, Iss. 7, pp. 936-951
Closed Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Regulated cell death and its role in Alzheimer’s disease and amyotrophic lateral sclerosis
Dietmar Rudolf Thal, Klara Gawor, Sebastiaan Moonen
Acta Neuropathologica (2024) Vol. 147, Iss. 1
Closed Access | Times Cited: 22
Disruption of cellular proteostasis by H1N1 influenza A virus causes α-synuclein aggregation
Rita Marreiros, Andreas Müller‐Schiffmann, Svenja V. Trossbach, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 12, pp. 6741-6751
Open Access | Times Cited: 108
Stress-primed secretory autophagy promotes extracellular BDNF maturation by enhancing MMP9 secretion
Silvia Martinelli, Elmira Anderzhanova, Thomas Bajaj, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 81
Emerging targeted protein degradation tools for innovative drug discovery: From classical PROTACs to the novel and beyond
Yue Zhong, Fanglian Chi, Hanyu Wu, et al.
European Journal of Medicinal Chemistry (2022) Vol. 231, pp. 114142-114142
Closed Access | Times Cited: 41
Network-Based Spreading of Gray Matter Changes Across Different Stages of Psychosis
Sidhant Chopra, Ashlea Segal, Stuart Oldham, et al.
JAMA Psychiatry (2023) Vol. 80, Iss. 12, pp. 1246-1246
Open Access | Times Cited: 32
Deep proteomics identifies shared molecular pathway alterations in synapses of patients with schizophrenia and bipolar disorder and mouse model
Sameer Aryal, Kevin Bonanno, Bryan J. Song, et al.
Cell Reports (2023) Vol. 42, Iss. 5, pp. 112497-112497
Open Access | Times Cited: 31
Amyloids, amorphous aggregates and assemblies of peptides – Assessing aggregation
Maja Juković, Ivana Ratkaj, Daniela Kalafatović, et al.
Biophysical Chemistry (2024) Vol. 308, pp. 107202-107202
Closed Access | Times Cited: 7
Elevated ubiquitinated proteins in brain and blood of individuals with schizophrenia
Chad A. Bousman, Sandra Luza, Serafino G. Mancuso, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 42
Molecular Mechanisms Linking ALS/FTD and Psychiatric Disorders, the Potential Effects of Lithium
Fiona Limanaqi, Francesca Biagioni, Larisa Ryskalin, et al.
Frontiers in Cellular Neuroscience (2019) Vol. 13
Open Access | Times Cited: 40
Co-Expression Network Analysis Identifies Molecular Determinants of Loneliness Associated with Neuropsychiatric and Neurodegenerative Diseases
José A. Santiago, James P. Quinn, Judith A. Potashkin
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5909-5909
Open Access | Times Cited: 12
Proteome analysis of the prefrontal cortex and the application of machine learning models for the identification of potential biomarkers related to suicide
Manuel Alejandro Rojo-Romero, Nora Gutiérrez-Nájera, Carlos Cruz-Fuentes, et al.
Frontiers in Psychiatry (2025) Vol. 15
Open Access
Impaired unfolded protein response, BDNF and synuclein markers in postmortem dorsolateral prefrontal cortex and caudate nucleus of patients with depression and Parkinson's disease
Unai Sarriés-Serrano, Lluís Miquel-Rio, Noemí Santana, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025) Vol. 138, pp. 111299-111299
Open Access
Protein aggregation identified in olfactory neuronal cells is associated with cognitive impairments in a subset of living schizophrenia patients
Leslie G. Nucifora, Koko Ishizuka, Nagat El Demerdash, et al.
Molecular Psychiatry (2025)
Open Access
Exploring bioactive natural products for treating neurodegenerative diseases: a computational network medicine approach targeting the estrogen signaling pathway in amyotrophic lateral sclerosis and Parkinson’s disease
Mayank Roy Chowdhury, Rajiv Reddy, Navaneeth K Nampoothiri, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 4
Closed Access
Long-term treatment with haloperidol modulates angiotensin I-converting enzyme (ACE) activity in transgenic animal model with construct validity for schizophrenia studies
William Y. Oyadomari, Thays Calista Santiago, Leonardo Cruz Basso, et al.
Brain Research (2025), pp. 149640-149640
Closed Access
Disrupted‐in‐schizophrenia 1 overexpression disrupts hippocampal coding and oscillatory synchronization
Karola Kaefer, Hugo Malagon‐Vina, Desiree Dickerson, et al.
Hippocampus (2019) Vol. 29, Iss. 9, pp. 802-816
Open Access | Times Cited: 28
Dysregulation of a specific immune-related network of genes biologically defines a subset of schizophrenia
Svenja V. Trossbach, Laura Hecher, David Schafflick, et al.
Translational Psychiatry (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 27
Intracellular compartment-specific proteasome dysfunction in postmortem cortex in schizophrenia subjects
Madeline R. Scott, James H. Meador‐Woodruff
Molecular Psychiatry (2019) Vol. 25, Iss. 4, pp. 776-790
Open Access | Times Cited: 25
Enhanced carbonyl stress induces irreversible multimerization of CRMP2 in schizophrenia pathogenesis
Manabu Toyoshima, Xuguang Jiang, T. Ogawa, et al.
Life Science Alliance (2019) Vol. 2, Iss. 5, pp. e201900478-e201900478
Open Access | Times Cited: 24
The Role of Cathepsins in Memory Functions and the Pathophysiology of Psychiatric Disorders
Christine Niemeyer, Natalie Matosin, Dominic Kaul, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 22
Molecular origin of somatostatin-positive neuron vulnerability
Toshifumi Tomoda, Akiko Sumitomo, Dwight F. Newton, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 4, pp. 2304-2314
Open Access | Times Cited: 13
Disrupted‐in‐schizophrenia 1 protein aggregates in cerebrospinal fluid are elevated in patients with first‐episode psychosis
Marlene Pils, Julia Rutsch, Feride Eren, et al.
Psychiatry and Clinical Neurosciences (2023) Vol. 77, Iss. 12, pp. 665-671
Open Access | Times Cited: 8
Disrupted-in-Schizophrenia 1 (DISC1) Overexpression and Juvenile Immune Activation Cause Sex-Specific Schizophrenia-Related Psychopathology in Rats
Taygun C. Uzuneser, Jil Speidel, Georgios Kogias, et al.
Frontiers in Psychiatry (2019) Vol. 10
Open Access | Times Cited: 20
The TRIOBP Isoforms and Their Distinct Roles in Actin Stabilization, Deafness, Mental Illness, and Cancer
Beti Zaharija, Bobana Samardžija, Nicholas J. Bradshaw
Molecules (2020) Vol. 25, Iss. 21, pp. 4967-4967
Open Access | Times Cited: 19
Which Severe Mental Illnesses Most Increase the Risk of Developing Dementia? Comparing the Risk of Dementia in Patients with Schizophrenia, Major Depressive Disorder and Bipolar Disorder
Wei Hung Chang, Chien‐Chou Su, Kao Chin Chen, et al.
Clinical Psychopharmacology and Neuroscience (2023) Vol. 21, Iss. 3, pp. 478-487
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top